A pretreatment nomogram to predict muscle-invasiveness in high-risk upper tract urothelial carcinoma (ROBUUST 2.0 collaborative group).
Ditonno F, Franco A, Bologna E, Veccia A, Bertolo R, Wang L, Abdollah F, Finati M, Simone G, Tuderti G, Helstrom E, Correa A, De Cobelli O, Ferro M, Porpiglia F, Amparore D, Checcucci E, Tufano A, Perdonà S, Bhanvadia R, Margulis V, Broenimann S, Singla N, Puri D, Derweesh IH, Mendiola DF, Gonzalgo ML, Ben-David R, Mehrazin R, Moon SC, Rais-Bahrami S, Yong C, Sundaram CP, Moghaddam FS, Ghoreifi A, Djaladat H, Autorino R, Wu Z, Antonelli A.
Ditonno F, et al. Among authors: finati m.
Minerva Urol Nephrol. 2025 Feb;77(1):57-68. doi: 10.23736/S2724-6051.25.05934-8.
Minerva Urol Nephrol. 2025.
PMID: 40183183
Free article.